Icad Financials

Earnings View

Profitability View

Liquidity View

Fundamentals View

Competition View

Icad Stock Summary

Icad competes with Profound Medical, Si Bone, Sight Sciences, Nevro Corp, and Paragon 28. iCAD, Inc. provides image analysis, workflow solutions, and radiation therapy for the treatment of cancer in the United States. The company was formerly known as Howtek, Inc. and changed its name to iCAD, Inc. in June 2002. iCAD, Inc. was incorporated in 1984 and is headquartered in Nashua, New Hampshire. Icad operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 136 people.

Icad Key Financial Ratios

There are many critical financial ratios that Icad's investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that icad inc reports annually and quarterly.

Icad Key Balance Sheet Accounts

Icad Key Income Statement Accounts

Icad Key Cash Accounts

Icad Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Icad's current stock value. Our valuation model uses many indicators to compare Icad value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Icad competition to find correlations between indicators driving Icad's intrinsic value. More Info.icad inc is rated third overall in return on equity category among its peers. It is rated fifth overall in return on asset category among its peers . At present, Icad's Return On Equity is projected to slightly decrease based on the last few years of reporting. Comparative valuation analysis is a catch-all technique that is used if you cannot value Icad by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.

icad inc Systematic Risk

Today, most investors in Icad Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Icad's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Icad growth as a starting point in their analysis.

Along with financial statement analysis, the daily predictive indicators of Icad help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of icad inc. We use our internally-developed statistical techniques to arrive at the intrinsic value of icad inc based on widely used predictive technical indicators. In general, we focus on analyzing Icad Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Icad's daily price indicators and compare them against related drivers.

When running Icad's price analysis, check to measure Icad's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Icad is operating at the current time. Most of Icad's value examination focuses on studying past and present price action to predict the probability of Icad's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Icad's price. Additionally, you may evaluate how the addition of Icad to your portfolios can decrease your overall portfolio volatility.